K. Rajkumar et al., HYPERGLYCEMIA AND IMPAIRED GLUCOSE-TOLERANCE IN IGF BINDING PROTEIN-1TRANSGENIC MICE, American journal of physiology: endocrinology and metabolism, 33(4), 1996, pp. 565-571
The insulin like growth factors (IGFs) are present in the serum in ass
ociation with high-affinity binding proteins (IGFBPs), which limit the
hypoglycemic insulin-like actions of these growth factors. By utilizi
ng the mouse phosphoglycerate kinase promoter to drive a rat genomic f
ragment, we developed three transgenic mouse strains that overexpresse
d IGFBP-1. Homozygous offspring demonstrated fasting hyperglycemia. Th
e blood glucose values were 4.97 +/- 0.37, 4.57 +/- 0.33, and 5.58 +/-
0.50 mM for transgenic mice compared with 3.33 +/- 0.19 mM (mean +/-
SE, P < 0.005) for the wild-type mice. The transgenic mice had more ma
rked hyperglycemia after an intraperitoneal glucose challenge. The fas
ting serum insulin levels were significantly elevated in the transgeni
c mice; however, the insulin-to-glucose ratio was only modestly elevat
ed in the fasting state and fell after a glucose challenge. Islet size
and number were significantly increased; however, pancreatic insulin
content was reduced (P < 0.05) compared with that of wild-type mice. T
he glucose response to subcutaneous insulin was similar in transgenic
and wild-type mice. These data demonstrate that constitutive overexpre
ssion of IGFBP-1 results in impaired glucose tolerance with normal ins
ulin sensitivity.